Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Optival Health Solutions Private Limited, a subsidiary of Medplus Health Services, has received two drug license suspension orders from the Assistant Director, Drugs Control Administration, Bangalore Circle - 3. The first order suspends the drug license of a store at Jayanagar 5th Block for 4 days (order dated April 16, 2026) with potential revenue loss of Rs 3.68 lakh. The second order suspends the drug license of a store at Srinivasanagar BSK 2nd Stage for 5 days with potential revenue loss of Rs 1.30 lakh. The violations are under Rule 65 of the Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945. The combined potential revenue loss across both stores is approximately Rs 4.98 lakh.
The financial impact is relatively minor at under Rs 5 lakh against the company's overall operations. However, it highlights regulatory compliance issues at subsidiary stores and could attract further scrutiny from drug authorities on other stores in Karnataka.